Clinical Trial

Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)

Name: Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS) — clinical trial record (NCT04871035)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: IPET-GBS

Recruiting

View on ClinicalTrials.gov →

Summary

This is an observations study evaluating safety and efficacy of immunoadsorption compared to plasma exchange in Guillain-Barré Syndrome.

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2021-04-28; most recent amendment 2026-04-30.

Trial Details

NCT Number	NCT04871035
Lead Sponsor	University of Ulm Collaborators: DiaMed GmbH
Conditions	GBS
Enrollment	20 participants
Start Date	2021-04-28
Primary Completion	2027-09-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-01